Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202507698362506Phase 3Completed
Phase 3 trial of dexmedetomidine (2 arms), sponsored by Suez Canal University. Primary endpoint: Time to first request of analgesia. Started Jun 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202507698362506.